Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Asthma · Osteoarthritis · AMRX

Amneal Pharma Europe

Amneal Pharma Europe Ltd

Amneal Pharma Europe patent portfolio — 32 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US HQ
2002 Founded
7,179 Employees
Public company Type
AMRX · NYSE Ticker
Company details
Status
Public
HQ
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
Founded
2002
Employees
7,179
Programs
15
Drugs
210
Patents
32
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Amneal Pharma Europe patents

32 pharmaceutical patents indexed for Amneal Pharma Europe. 0 expire within 24 months.

Amneal Pharma Europe has 32 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

32 patents

Patent portfolio

  1. US 12383522

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12370163

    Levodopa dosing regimen

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12303481

    Levodopa dosing regimen

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12303482

    Levodopa dosing regimen

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12295931

    Levodopa dosing regimen

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12263148

    Levodopa dosing regimen

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12263149

    Levodopa dosing regimen

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12233166

    Extended release compositions comprising pyridostigmine

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12201596

    Levodopa dosing regimen

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12194150

    Levodopa dosing regimen

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12109185

    Levodopa dosing regimen

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12011502

    Compositions and methods of administering baclofen

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11986449

    Levodopa dosing regimen

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11931328

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11911515

    Extended release compositions comprising pyridostigmine

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11850225

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11666536

    Extended release compositions comprising pyridostigmine

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11654124

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11564888

    Extended release compositions comprising trihexyphenidyl

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11547670

    Delayed release methylphenidate compositions

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11523984

    Compositions and methods of administering baclofen

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11491125

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11478425

    Extended release compositions comprising pyridostigmine

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11439585

    Programmable pharmaceutical compositions for chrono drug release

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11318091

    Gastroretentive dosage forms for sustained drug delivery

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11229606

    Extended release compositions comprising pyridostigmine

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11179320

    Self-regulating osmotic gastroretentive drug delivery systems

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11166906

    Programmable pharmaceutical compositions for chrono drug release

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11154494

    Programmable pharmaceutical compositions for chrono drug release

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10052467

    Applicator for applying a fluid to a surface

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9629805

    Stabilization of moisture-sensitive drugs

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9227044

    Applicator for applying a fluid to a surface

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Amneal Pharma Europe have?

32 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Amneal Pharma Europe patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.